Anders Österborg
Anknuten till Forskning
E-postadress: anders.osterborg@ki.se
Besöksadress: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postadress: K7 Onkologi-Patologi, K7 Forskning Österborg, 171 77 Stockholm
Artiklar
- Article: BLOOD. 2024;:blood.2024024667
- Article: CELL HOST AND MICROBE. 2024;32(2):156-161.e3
- Article: SCIENCE IMMUNOLOGY. 2023;8(90):eadh0687
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(5):715-721
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(5):748-756
- Article: JOURNAL OF HEMATOLOGY. 2023;12(4):170-175
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(21):3689-3699
- Article: SCIENCE TRANSLATIONAL MEDICINE. 2023;15(704):eadg9452
- Article: BLOOD ADVANCES. 2023;7(12):2794-2806
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(5):1035-1045
- Article: NEW ENGLAND JOURNAL OF MEDICINE. 2023;388(4):319-332
- Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 2023;388(4):319-332
- Article: LEUKEMIA RESEARCH. 2022;122:106945
- Article: PHARMACEUTICS. 2022;14(10):2238
- Article: IMMUNITY. 2022;55(9):1732-1746.e5
- Article: THE LANCET ONCOLOGY. 2022;23(8):1031-1043
- Article: NEJM EVID. 2022;1(7):evidoa2200006
- Article: NATURE MEDICINE. 2022;28(3):472-476
- Article: CANCERS. 2022;14(5):1186
- Article: MED. 2022;3(2):137-153.e3
- Article: MOLECULAR MEDICINE. 2022;28(1):20
- Article: LEUKEMIA. 2022;36(2):476-481
- Article: BLOOD. 2021;138(18):1768-1773
- Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2021;156:106575
- Article: HAEMATOLOGICA. 2021;106(9):2354-2363
- Article: EJHAEM. 2021;2(3):498-502
- Article: HANDBOOK OF EXPERIMENTAL PHARMACOLOGY. 2021;269:75-99
- Article: HAEMATOLOGICA. 2021;106(1):87-97
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;191(3):426-432
- Article: BLOOD. 2020;136(10):1134-1143
- Article: LEUKEMIA AND LYMPHOMA. 2020;61(9):2136-2144
- Article: BIOMEDICINES. 2020;8(6):E170-170
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):689-693
- Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2020;476:112675
- Article: HAEMATOLOGICA. 2019;104(4):797-804
- Article: LEUKEMIA. 2018;32(10):2291-2295
- Article: ANNALS OF ONCOLOGY. 2018;29(Suppl 4):iv96-iv110
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;183(2):212-224
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;182(4):504-512
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):68-77
- Article: JOURNAL OF IMMUNOTHERAPY. 2018;41(2):73-83
- Article: PLOS ONE. 2018;13(6):e0198038
- Article: PLOS ONE. 2018;13(2):e0192839
- Article: ONCOTARGET. 2017;8(61):103731-103743
- Article: ANNALS OF HEMATOLOGY. 2017;96(10):1681-1691
- Article: HAEMATOLOGICA. 2017;102(3):562-572
- Article: ONCOTARGET. 2017;8(6):10213-10224
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2017;66(1):91-102
- Article: ONCOLOGY LETTERS. 2016;12(4):2782-2788
- Article: THE LANCET ONCOLOGY. 2016;17(10):1409-1418
- Article: TUMOR BIOLOGY. 2016;37(9):11947-11957
- Article: LEUKEMIA AND LYMPHOMA. 2016;57(9):2037-2046
- Article: EXPERIMENTAL HEMATOLOGY. 2016;44(1):38-49.e1
- Article: MOLECULAR IMMUNOLOGY. 2015;66(2):164-170
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;170(1):40-49
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2015;45(6):1783-1793
- Article: FUTURE ONCOLOGY. 2015;11(1):51-59
- Article: PLOS ONE. 2015;10(11):e0142310
- Article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2014;10(11):3394-3408
- Article: SUPPORTIVE CARE IN CANCER. 2014;22(8):2197-2206
- Article: LEUKEMIA AND LYMPHOMA. 2014;55(8):1774-1780
- Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2014;54(7):818-827
- Article: LEUKEMIA AND LYMPHOMA. 2014;55(5):1158-1165
- Article: MEDICAL ONCOLOGY. 2013;30(4):759
- Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2013;2(1):23
- Article: EXPERIMENTAL HEMATOLOGY. 2013;41(7):615-626
- Article: LEUKEMIA AND LYMPHOMA. 2013;54(5):996-1003
- Article: LEUKEMIA AND LYMPHOMA. 2013;54(4):843-850
- Article: EXPERIMENTAL CELL RESEARCH. 2013;319(5):600-611
- Article: PLOS ONE. 2013;8(6):e67601
- Article: PLOS ONE. 2013;8(10):e78339
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2013;62(1):51-63
- Article: LEUKEMIA AND LYMPHOMA. 2012;53(11):2151-2158
- Article: CANCER RESEARCH. 2012;72(20):5348-5362
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(25):3093-3099
- Article: LEUKEMIA. 2012;26(6):1348-1355
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2012;61(6):865-879
- Article: CLINICAL CANCER RESEARCH. 2012;18(8):2230-2239
- Article: MEDICAL ONCOLOGY. 2011;28(4):1210-1217
- Article: BLOOD. 2011;118(19):5126-5129
- Article: ANNALS OF ONCOLOGY. 2011;22(3):664-670
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;151(4):327-335
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;150(5):565-573
- Article: PLOS ONE. 2010;5(7):e11483
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(10):1749-1755
- Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2010;10(3):439-449
- Article: CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY. 2010;8(1):28-30
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2009;69(6):529-536
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(1):78-85
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2009;58(1):111-120
- Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(5):1190-1195
- Article: ANNALS OF ONCOLOGY. 2008;19(6):1172-1179
- Article: INVESTIGATIONAL NEW DRUGS. 2008;26(2):139-149
- Article: ACTA ONCOLOGICA. 2008;47(6):1009-1017
- Article: SUPPORTIVE CARE IN CANCER. 2008;16(1):57-65
- Article: CYTOMETRY. PART A : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR ANALYTICAL CYTOLOGY. 2007;72B(6):450-457
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2007;79(5):371-381
- Article: BRITISH JOURNAL OF CANCER. 2007;97(6):769-777
- Article: MEDICAL ONCOLOGY. 2007;24(3):267-272
- Article: BRITISH JOURNAL OF CANCER. 2007;97(1):105-111
- Article: CLINICAL CANCER RESEARCH. 2007;13(12):3536-3544
- Article: BLOOD. 2007;109(11):4655-4662
- Article: CLINICAL CANCER RESEARCH. 2007;13(5):1503-1510
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2007;136(5):736-744
- Article: EXPERIMENTAL HEMATOLOGY. 2007;35(2):297-304
- Article: HAEMATOLOGICA. 2007;92(1):110-114
- Article: BRITISH JOURNAL OF CANCER. 2006;95(11):1467-1473
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2006;135(4):475-485
- Article: LEUKEMIA AND LYMPHOMA. 2006;47(7):1229-1238
- Article: BLOOD. 2006;107(2):669-678
- Article: CYTOTHERAPY. 2006;8(4):318-326
- Article: BLOOD. 2005;106(4):1346-1354
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;129(2):206-209
- Article: INTERNATIONAL JOURNAL OF CANCER. 2005;113(5):730-737
- Article: MEDICAL ONCOLOGY. 2005;22(3):291-302
- Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2004;33(6):423-427
- Article: LEUKEMIA. 2004;18(11):1810-1815
- Article: EUROPEAN JOURNAL OF CANCER. 2004;40(15):2201-2216
- Article: SEMINARS IN HEMATOLOGY. 2004;41(3):234-245
- Article: BLOOD. 2004;103(8):3138-3147
- Article: BLOOD. 2004;103(8):2920-2924
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2004;124(3):315-324
- Article: LEUKEMIA. 2004;18(1):41-47
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2003;58(6):601-606
- Article: BLOOD. 2003;101(12):4930-4936
- Article: BLOOD. 2003;101(11):4607-4610
- Article: BLOOD. 2003;101(11):4267-4272
- Article: LEUKEMIA. 2003;17(5):894-899
- Article: BLOOD. 2003;101(3):1063-1070
- Article: HEMATOLOGY JOURNAL. 2003;4(4):248-252
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(1):79-86
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2002;20(10):2486-2494
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2002;68(5):299-306
- Article: MEDICAL ONCOLOGY. 2002;19(4):277-280
- Article: MEDICAL ONCOLOGY. 2002;19:S21-S26
- Article: LEUKEMIA. 2001;15(12):1868-1877
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;115(2):263-271
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(4):1020-1034
- Article: INTERNATIONAL JOURNAL OF CANCER. 2001;95(3):184-188
- Article: CLINICAL IMMUNOLOGY. 2001;99(1):65-74
- Article: HEMATOLOGY JOURNAL. 2001;2(5):300-306
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;112(1):155-160
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;111(2):608-617
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;111(1):230-238
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;109(1):39-45
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1999;63(3):163-170
- Article: BLOOD. 1999;94(3):1063-1069
- Article: EUROPEAN JOURNAL OF CANCER. 1999;35:S29-S32
- Article: INTERNATIONAL JOURNAL OF CANCER. 1999;80(5):671-680
- Article: PATHOLOGIE ET BIOLOGIE. 1999;47(2):211-215
- Article: JOURNAL OF CLINICAL ONCOLOGY. 1998;16(12):3832-3842
- Article: JOURNAL OF CLINICAL ONCOLOGY. 1998;16(10):3257-3263
- Article: BLOOD. 1998;92(2):402-404
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1997;27(9):2245-2252
- Article: BLOOD. 1997;90(5):1960-1967
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997;234(2):296-299
- Article: JOURNAL OF CLINICAL ONCOLOGY. 1997;15(4):1567-1574
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1997;96(2):338-345
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;58(1):5-13
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;94(3):425-432
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;93(1):151-153
- Article: MEDICAL ONCOLOGY. 1996;13(1):1-7
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(4):840-846
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(1):71-76
- Article: BLOOD. 1995;86(8):3043-3049
- Article: INTERNATIONAL JOURNAL OF CANCER. 1995;63(2):190-192
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 1995;89(1):110-116
- Visa fler
Alla övriga publikationer
- Editorial comment: FUTURE ONCOLOGY. 2024;20(12):717-726
- Letter: HAEMATOLOGICA. 2024;109(2):646-651
- Letter: ACTA ONCOLOGICA. 2023;62(6):560-564
- Letter: BLOOD. 2022;140(22):2403-2407
- Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(4):e13153
- Review: FRONTIERS IN IMMUNOLOGY. 2021;12:686768
- Review: CANCERS. 2019;11(7):E915-915
- Letter: HAEMATOLOGICA. 2019;104(5):e208-e210
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2019;185(1):179-183
- Meeting abstract: BLOOD. 2018;132:4130
- Meeting abstract: BLOOD. 2018;132:2868
- Corrigendum: ANNALS OF ONCOLOGY. 2018;29(Suppl 4):iv271
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2018;182(4):590-594
- Meeting abstract: MOLECULAR IMMUNOLOGY. 2017;89:203
- Letter: LEUKEMIA AND LYMPHOMA. 2017;58(5):1219-1223
- Review: ANNALS OF ONCOLOGY. 2017;28(2):218-227
- Meeting abstract: BLOOD. 2016;128(22):3235
- Meeting abstract: ANNALS OF ONCOLOGY. 2016;27:vi530
- Review: JOURNAL OF DRUG TARGETING. 2016;24(5):373-385
- Review: CANCER TREATMENT REVIEWS. 2016;45:68-75
- Meeting abstract: BLOOD. 2015;126(23):2912
- Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2015;82(3):208-217
- Letter: HAEMATOLOGICA. 2015;100(8):e311-e314
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2015;169(3):455-458
- Review: SEMINARS IN CANCER BIOLOGY. 2014;29:21-31
- Meeting abstract: CANCER RESEARCH. 2014;74(19):4770
- Meeting abstract: CANCER RESEARCH. 2014;74(19):3184
- Review: CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. 2014;89(1):1-15
- Meeting abstract: MOLECULAR IMMUNOLOGY. 2013;56(3):292
- Review: CANCER TREATMENT REVIEWS. 2013;39(6):632-639
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2012;159(5):608-612
- Meeting abstract: BLOOD. 2012;120(21):1612
- Meeting abstract: BLOOD. 2012;120(21):4583
- Meeting abstract: BLOOD. 2012;120(21):1769
- Review: ANNALS OF ONCOLOGY. 2012;23(8):1954-1962
- Meeting abstract: CANCER RESEARCH. 2012;72:3027
- Other: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2012;61(4):587-591
- Other: MEDICAL ONCOLOGY. 2011;28(4):1626
- Letter: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(17):e525-e526
- Letter: BLOOD CANCER JOURNAL. 2011;1(6):e22
- Review: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2010;10(5):361-368
- Corrigendum: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2010;10(2):157
- Meeting abstract: CLINICAL LYMPHOMA AND MYELOMA. 2009;9(6):e36
- Review: LEUKEMIA. 2009;23(11):1980-1988
- Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2009;27(17):2838-2847
- Review: CURRENT HEMATOLOGIC MALIGNANCY REPORTS. 2009;4(1):47-53
- Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2008;83(11):880
- Published conference paper: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2008;57(11):1705-1710
- Editorial comment: THE LANCET ONCOLOGY. 2008;9(5):412-413
- Meeting abstract: BLOOD. 2007;110(11):999A
- Meeting abstract: BLOOD. 2007;110(11):242B
- Meeting abstract: EJC SUPPLEMENTS. 2007;5(4):147-148
- Meeting abstract: EJC SUPPLEMENTS. 2007;5(4):142-143
- Review: EUROPEAN JOURNAL OF CANCER. 2007;43(3):510-519
- Review: EUROPEAN JOURNAL OF CANCER. 2007;43(2):258-270
- Meeting abstract: BLOOD. 2006;108(11):4B
- Meeting abstract: BLOOD. 2006;108(11):770A
- Published conference paper: ANNALS OF ONCOLOGY. 2006;17:x144-x154
- Review: SEMINARS IN ONCOLOGY. 2006;33(2):S29-S35
- Letter: BLOOD. 2005;105(10):4148-4149
- Meeting abstract: BLOOD. 2004;104(11):184A-185A
- Meeting abstract: BLOOD. 2004;104(11):689A
- Meeting abstract: BLOOD. 2004;104(11):419A
- Meeting abstract: BLOOD. 2004;104(11):288B
- Meeting abstract: BLOOD. 2004;104(11):54A
- Review: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2004;5(3):203-214
- Published conference paper: SEMINARS IN ONCOLOGY. 2004;31(3):12-18
- Review: CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY. 2004;2(4):233-241
- Review: CLINICAL LYMPHOMA AND MYELOMA. 2004;4(4):220-227
- Letter: LEUKEMIA. 2003;17(11):2252-2254
- Letter: CANCER. 2003;97(12):3125-3126
- Editorial comment: DRUGS. 2003;63(12):1245-1246
- Review: HEMATOLOGY JOURNAL. 2002;3(3):121-130
- Review: MEDICAL ONCOLOGY. 2000;17:S17-S22
- Published conference paper: ACTA ONCOLOGICA. 2000;39(7):797-800
- Review: CURRENT OPINION IN HEMATOLOGY. 1999;6(3):169-175
- Editorial comment: MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY. 1999;16(1):1
- Review: SEMINARS IN IMMUNOPATHOLOGY. 1999;21(1):19-35
- Review: MEDICAL ONCOLOGY. 1998;15 Suppl 1:S47-S49
- Review: LAKARTIDNINGEN. 1998;95(13):1405-1410
- Editorial comment: MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY. 1996;13(3):R3
- Visa fler